Ann: FRG Trials on Tuberculosis, page-257

It’s a possibility that these big names have seen the tech and it’s capabilities and they are desperate to get po3 to execute licensing agreements and start manufacturing! PO3 has got something that all these players want because it means more revenue for these players, Im wondering if Dilato holdings will sell a stake of shares in accordance with an agreement of the role out to these big players! Who knows I’m just an investor and a mere spectator